Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 75 | 0 | 13 | 0 | €820.10 | €831.01 | 1.330% |
| Vertex Pharmaceuticals Inc. | 59 | 2 | 2 | 0 | €428.15 | €450.36 | 5.188% |
| Boston Scientific | 56 | 0 | 4 | 0 | €75.00 | €78.23 | 4.312% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | €1,030.5 | €1,087.6 | 5.537% |
| Insmed Inc. | 46 | 0 | 2 | 0 | €65.50 | €77.15 | 17.786% |
| Alnylam Pharmace. | 45 | 0 | 5 | 0 | €247.60 | €275.25 | 11.167% |
| UnitedHealth Group Inc. | 45 | 1 | 5 | 0 | €517.00 | €546.99 | 5.801% |
| Neurocrine Bioscience | 42 | 0 | 5 | 0 | €107.90 | €155.89 | 44.476% |
| Tenet Healthcare | 41 | 0 | 1 | 0 | €150.00 | €154.91 | 3.275% |
| Johnson & Johnson | 40 | 1 | 4 | 0 | €147.68 | €193.85 | 31.267% |
| HCA Holdings Inc. | 40 | 0 | 3 | 0 | €361.50 | €356.58 | -1.360% |
| Intuitive Surgical Inc | 37 | 0 | 3 | 0 | €438.95 | €414.56 | -5.557% |
| Acadia Pharmaceuticals | 36 | 1 | 1 | 0 | €14.72 | €29.92 | 103.299% |
| Cytokinetics Inc. | 35 | 1 | 5 | 0 | €49.80 | €83.13 | 66.930% |
| Edwards Lifesciences Corp. | 35 | 1 | 3 | 0 | €60.21 | €82.91 | 37.698% |
| Intra-Cellular Therapies Inc. | 35 | 0 | 5 | 0 | €69.00 | €85.00 | 23.188% |
| AbbVie Inc. | 34 | 0 | 1 | 0 | €173.46 | €180.90 | 4.291% |
| Stryker Corp. | 33 | 0 | 4 | 0 | €327.10 | €342.93 | 4.839% |
| Illumina Inc. | 33 | 4 | 3 | 0 | €120.40 | €158.42 | 31.581% |
| Jazz Pharmaceuticals plc | 32 | 0 | 3 | 0 | €99.70 | €183.41 | 83.966% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €105.00 | €126.38 | 20.362% |
| Thermo Fisher Scientific Inc. | 31 | 0 | 2 | 0 | €555.80 | €573.15 | 3.122% |
| Pfizer Inc. | 30 | 4 | 6 | 0 | €26.58 | €40.68 | 53.093% |
| BioMarin Pharmaceutical Inc. | 29 | 0 | 12 | 0 | €64.00 | €100.74 | 57.403% |
| Cigna Corp. | 28 | 0 | 6 | 0 | €320.10 | €360.98 | 12.771% |